J Korean Neuropsychiatr Assoc.
2004 Jul;43(4):481-484.
Interferon-alpha2b Induced Bipolar Syndrome in Patient with Melanoma: A Case Report
- Affiliations
-
- 1Department of Psychiatry, School of Medicine, Inha University, Incheon, Korea. kce320@inha.ac.kr
- 2Department of Internal Medicine, School of Medicine, Inha University, Incheon, Korea.
Abstract
- The use of a high dose regimen of interferon (INF) has recently been demonstrated to benefit patients with malignant melanoma and the use of high dose INF for stage IIB and III melanoma was approved by Food and Drug Administration in 1995. The therapeutic benefits of INF are sometimes hampered by their severe and troublesome adverse effects including depression, mania, and cognitive impairment. The authors report a melanoma patient treated with adjuvant INF-alpha2b who developed a manic-depressive syndrome or mood instability with therapy and we reviewed literatures on mania and mixed affective syndrome associated with INF.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Efficacy of Interferon-alpha2b in Treatment of Warts
- The Analysis of Post Operative Treatment of Malignant Melanoma Using High Dose Interferon-alpha2b Immunotherapy: Preliminary Report
- Cutaneous Ulceration after Injection of Interferon Alpha in a Melanoma Patient
- Late Mumps Orchitis: Clinical Manifestations in 20 cases Effect of Interferon-alpha2b
- Vogt-Koyanagi-Harada disease occurring during pegylated interferon-alpha2b and ribavirin combination therapy for chronic hepatitis C
